Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes

  1. Peter Hovind, MD1,
  2. Lise Tarnow, DMSC, MD1,
  3. Kasper Rossing, MD1,
  4. Peter Rossing, DMSC, MD1,
  5. Stefanie Eising, MD1,
  6. Nicolai Larsen, MD, PHD1,
  7. Christian Binder, DMSC, MD1 and
  8. Hans-Henrik Parving, DMSC, MD12
  1. 1Steno Diabetes Center, Gentofte, Denmark
  2. 2Faculty of Health Science, University of Aarhus, Aarhus, Denmark
    Diabetes Care 2003 Apr; 26(4): 1258-1264. https://doi.org/10.2337/diacare.26.4.1258
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • Figure 1—
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 1—

      Cumulative incidence of diabetic nephropathy in 600 type 1 diabetic patients with onset of diabetes from 1965 to 1969 (n = 113, group A [○]), 1970 to 1974 (n = 130, group B [•]), 1975 to 1979 (n = 113, group C [□]), and 1979 to 1984 (n = 244, group D [▪]). P < 0.001, log-rank test, pooled over strata. Not all patients in group D have yet been followed for 20 years. For pairwise log-rank test over strata after 20 years of diabetes, see results.

    • Figure 2—
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 2—

      Cumulative incidence of proliferative retinopathy in 600 type 1 diabetic patients with onset of diabetes from 1965 to 1969 (n = 113, group A [○]), 1970 to 1974 (n = 130, group B [•]), 1975 to 1979 (n = 113, group C [□]), and 1979 to 1984 (n = 244, group D [▪]). P < 0.001, log-rank test, pooled over strata. Not all patients in group D have yet been followed for 20 years. For pairwise log-rank test over strata after 20 years of diabetes, see results.

    Tables

    • Figures
    • Table 1—

      Patient characteristics and clinical and laboratory data during 20 years of follow-up in 600 patients with type 1 diabetes

      Group A (onset from 1965 to 1969)Group B (onset from 1970 to 1974)Group C (onset from 1975 to 1979)Group D (onset from 1979 to 1984)P
      n113130113244—
      Sex (M/F)62/5172/5865/48144/100NS
      Age at onset of diabetes (years)*19.8 ± 10.620.9 ± 9.823.1 ± 8.623.2 ± 8.80.003
      Smoking (%)69546545<0.001
      During follow-up
          HbA1c (%)†8.9 ± 0.18.8 ± 0.18.9 ± 0.18.5 ± 0.10.006
          Systolic blood pressure (mmHg)†138.1 ± 1.2134.6 ± 1.3131.9 ± 1.3127.9 ± 0.8<0.001
          Diastolic blood pressure (mmHg)†84.7 ± 0.782.9 ± 0.781.7 ± 0.779.2 ± 0.5<0.001
          Mean arterial blood pressure (mmHg)†102.5 ± 0.8100.1 ± 0.898.4 ± 0.895.4 ± 0.6<0.001
          Class of antihypertensive treatment (ACE inhibitor/non-ACE inhibitor)15/2429/1728/655/6<0.001
          Time from diabetes onset to start of antihypertensive treatment (years)16.9 ± 0.414.8 ± 0.513.9 ± 0.813.3 ± 0.6<0.001
      • Data are

      • *

        ↵* *means ± SD or

      • †

        ↵† means ± SE unless otherwise indicated.

    PreviousNext
    Back to top
    Diabetes Care: 26 (4)

    In this Issue

    April 2003, 26(4)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
    Peter Hovind, Lise Tarnow, Kasper Rossing, Peter Rossing, Stefanie Eising, Nicolai Larsen, Christian Binder, Hans-Henrik Parving
    Diabetes Care Apr 2003, 26 (4) 1258-1264; DOI: 10.2337/diacare.26.4.1258

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
    Peter Hovind, Lise Tarnow, Kasper Rossing, Peter Rossing, Stefanie Eising, Nicolai Larsen, Christian Binder, Hans-Henrik Parving
    Diabetes Care Apr 2003, 26 (4) 1258-1264; DOI: 10.2337/diacare.26.4.1258
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • RESEARCH DESIGN AND METHODS
      • RESULTS
      • CONCLUSIONS
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition
    • Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes
    • High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
    Show more Pathophysiology/Complications

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.